Columbia Asset Management’s Gilead Sciences GILD Stock Holding History

Columbia Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$430K	Hold	3,085	–	–	0.08%	123
2025 Q4	$379K	Hold	3,085	–	–	0.07%	133
2025 Q3	$342K	Hold	3,085	–	–	0.06%	133
2025 Q2	$342K	Hold	3,085	–	–	0.07%	135
2025 Q1	$346K	Sell	3,085 -825	-21%	-$85.1K	0.07%	154
2024 Q4	$361K	Hold	3,910	–	–	0.07%	152
2024 Q3	$328K	Hold	3,910	–	–	0.06%	151
2024 Q2	$268K	Hold	3,910	–	–	0.05%	155
2024 Q1	$317K	Hold	3,910	–	–	0.06%	143
2023 Q4	$317K	Buy	3,910 +50	+1%	+$3.89K	0.06%	143
2023 Q3	$289K	Sell	3,860 -85	-2%	-$6.54K	0.06%	138
2023 Q2	$304K	Hold	3,945	–	–	0.06%	139
2023 Q1	$327K	Hold	3,945	–	–	0.07%	133
2022 Q4	$339K	Hold	3,945	–	–	0.08%	126
2022 Q3	$243K	Hold	3,945	–	–	0.06%	149
2022 Q2	$244K	Buy	+3,945	New	+$244K	0.06%	151
2021 Q4	$617K	Sell	8,503 -2,247	-21%	-$155K	0.13%	108
2021 Q3	$751K	Buy	10,750 +1,492	+16%	+$105K	0.16%	97
2021 Q2	$637K	Buy	9,258 +1,342	+17%	+$89.6K	0.14%	105
2021 Q1	$512K	Buy	7,916 +3,058	+63%	+$197K	0.09%	123
2020 Q4	$283K	Buy	4,858 +3	+0.1%	+$181	0.06%	154
2020 Q3	$307K	Sell	4,855 -5,047	-51%	-$350K	0.07%	138
2020 Q2	$762K	Sell	9,902 -4,409	-31%	-$338K	0.18%	87
2020 Q1	$1.07M	Buy	14,311 +7,195	+101%	+$497K	0.26%	67
2019 Q4	$4.62K	Buy	7,116 +675	+10%	+$44K	0.11%	127
2019 Q3	$408K	Buy	6,441 +250	+4%	+$16.3K	0.11%	130
2019 Q2	$418K	Buy	6,191 +2,630	+74%	+$173K	0.11%	134
2019 Q1	$232K	Sell	3,561 -100	-3%	-$6.65K	0.06%	163
2018 Q4	$229K	Sell	3,661 -600	-14%	-$41.9K	0.07%	146
2018 Q3	$329K	Hold	4,261	–	–	0.09%	136
2018 Q2	$302K	Sell	4,261 -3,000	-41%	-$212K	0.09%	139
2018 Q1	$547K	Buy	7,261 +1,475	+25%	+$117K	0.16%	115
2017 Q4	$415K	Buy	5,786 +350	+6%	+$26.6K	0.12%	134
2017 Q3	$440K	Buy	5,436 +1,755	+48%	+$134K	0.14%	126
2017 Q2	$260K	Hold	3,681	–	–	0.08%	153
2017 Q1	$250K	Sell	3,681 -1,324	-26%	-$93.1K	0.08%	155
2016 Q4	$358K	Buy	5,005 +250	+5%	+$18.6K	0.12%	136
2016 Q3	$376K	Sell	4,755 -2,610	-35%	-$212K	0.13%	130
2016 Q2	$614K	Buy	7,365 +100	+1%	+$8.88K	0.22%	98
2016 Q1	$667K	Sell	7,265 -516	-7%	-$46.5K	0.25%	94
2015 Q4	$787K	Buy	7,781 +300	+4%	+$31.2K	0.32%	84
2015 Q3	$735K	Buy	7,481 +75	+1%	+$8.33K	0.3%	88
2015 Q2	$867K	Buy	7,406 +175	+2%	+$19.1K	0.33%	82
2015 Q1	$710K	Sell	7,231 -150	-2%	-$15.2K	0.27%	103
2014 Q4	$696K	Sell	7,381 -675	-8%	-$69.8K	0.27%	98
2014 Q3	$858K	Sell	8,056 -1,875	-19%	-$184K	0.35%	82
2014 Q2	$823K	Buy	9,931 +2,600	+35%	+$202K	0.33%	85
2014 Q1	$519K	Sell	7,331 -100	-1%	-$7.84K	0.23%	102
2013 Q4	$558K	Buy	+7,431	New	+$517K	0.25%	96

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Columbia Asset Management's GILD Position: Q1 2026 in Review

Columbia Asset Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 3,085 shares worth $430K. The position accounts for 0.08% of the portfolio, ranked #123.

Columbia Asset Management first reported a position in GILD in Q4 2013 and has held it in 49 quarters since. The position peaked at $1.07M in Q1 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Columbia Asset Management held 3,085 shares of Gilead Sciences worth $430K as of Q1 2026.
Columbia Asset Management left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.08% of Columbia Asset Management's portfolio in Q1 2026, its #123 holding.
Columbia Asset Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 49 quarters since.
Columbia Asset Management's Gilead Sciences position peaked at $1.07M in Q1 2020.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Columbia Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.